Israel’s Teva and Gamida Cell Ltd have completed enrolment of patients for their Phase III clinical trial of StemEx, a cell therapy for the treatment of leukemia and lymphoma. StemEx is for adolescents and adults who cannot find family-related, matched bone marrow donors.
http://www.globes.co.il/serveen/globes/docview.asp?did=1000724616
Phase 3 trial starts for blood cancer treatment
This entry was posted in Israel's Medical Achievements. Bookmark the permalink.